Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 3/20 | 0.34 |
| ▸ | CA2 | P00918 | 3/20 | 0.34 |
| ▸ | CA4 | P22748 | 2/20 | 0.34 |
| ▸ | CES2 | O00748 | 1/20 | 0.32 |
| ▸ | CES1 | P23141 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | CA12 | O43570 | 1/20 | 0.30 |
| ▸ | CA7 | P43166 | 1/20 | 0.30 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphine SCHEMBL30084364 | 0.98 | CA1 (0.33) | CA1CA2CA4CES2CES1 | |
| SCHEMBL3671745 | 0.86 | CA1 (0.32) | CA1CA2CA4CES2CES1 | |
| SCHEMBL29396896 | 0.86 | CA1 (0.32) | CA1CA2CA4CES2CES1 | |
| SCHEMBL8156122 | 0.85 | — | — | |
| Benzene SCHEMBL29853972 | 0.82 | CA1 (0.30) | CA1CA2CA4 | |
| SCHEMBL7626884 | 0.81 | — | — | |
| SCHEMBL1483899 | 0.79 | CA1 (0.32) | CA1CA2CA4CES2CES1 | |
| SCHEMBL28407176 | 0.79 | — | — | |
| Trimethylammonium SCHEMBL28070834 | 0.79 | — | — | |
| SCHEMBL166503 | 0.78 | CA1 (0.31) | CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 287 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105985463-B | Bridged metallocene compound catalyst, preparation method and application thereof | 中国石油天然气股份有限公司 | 2018-04-03 | — | — | CN | claimed |
| CN-106699949-A | Ethylene-alpha olefin-non-conjugated diene polymer and preparation method thereof | 中国石油化工股份有限公司 | 2017-05-24 | — | — | CN | claimed |
| CN-104448062-B | Preparation method of metallocene catalyst | 中国石油天然气股份有限公司 | 2017-02-15 | — | — | CN | claimed |
| CN-106366226-A | Transition metal catalyst composition and applications thereof | 中国石油化工股份有限公司 | 2017-02-01 | — | — | CN | claimed |
| CN-105985463-A | Bridged metallocene compound catalyst, preparation method and application thereof | 中国石油天然气股份有限公司 | 2016-10-05 | — | — | CN | claimed |
| CN-105985384-A | Dinuclear metallocene compound, preparation method and application thereof | 中国石油天然气股份有限公司 | 2016-10-05 | — | — | CN | claimed |
| CN-104448062-A | Preparation method of metallocene catalyst | PETROCHINA CO LTD | 2015-03-25 | — | — | CN | claimed |
| CN-104159929-A | Supported composite metallocene catalyst, method for preparing the same, and method for preparing polyolefin using the same | SK INNOVATION CO LTD | 2014-11-19 | — | — | CN | claimed |
| CN-1178949-C | Cyclopentadienyl transition metal compounds, as polymerization catalysts | �Ϻ���ͨ��ѧ | 2004-12-08 | — | — | CN | claimed |
| CN-1302303-A | Cyclopentadienyl transition metal compounds, as polymerization catalysts | EASTMAN CHEM CO (US) | 2001-07-04 | — | — | CN | claimed |
| US-12637524-B2 | Polymerization catalyst having a tetradentate ligand | NOVA CHEMICALS (INTERNATIONAL) S.A. (CH) | 2026-05-26 | — | — | US | disclosed |
| CN-117402275-B | Metallocene catalyst and preparation method thereof | 中国石油天然气股份有限公司 | 2026-05-15 | — | — | CN | disclosed |
| US-20260103484-A1 | TRANSITION METAL COMPOUND, CATALYST COMPOSITION COMPRISING THE SAME, AND METHOD FOR PREPARING OLEFIN POLYMER USING THE SAME | SABIC SK NEXLENE COMPANY PTE LTD (SG) | 2026-04-16 | — | — | US | disclosed |
| US-12486342-B2 | Cyclopentadienyl/adamantyl phosphinimine zirconium and hafnium complexes | NOVA CHEMICALS (INTERNATIONAL) S.A. (CH) | 2025-12-02 | — | — | US | disclosed |
| EP-4139320-B1 | CYCLOPENTADIENYL/ADAMANTYL PHOSPHINIMINE ZIRCONIUM AND HAFNIUM COMPLEXES | NOVA CHEMICALS INTERNATIONAL SA (CH) | 2025-08-20 | — | — | EP | disclosed |
| CN-1194650-A | Transition metal complexes, catalyst for olefin polymerization, and process for producing olefin polymers | SUMITOMO CHEMICAL CO (JP) | 1998-09-30 | — | — | CN | disclosed |
| CN-1193323-A | Transition metal complex, process for producing the same, olefin polymerization catalyst containing the transition metal complex, and process for producing olefin polymer | SUMITOMO CHEM IND (JP) | 1998-09-16 | — | — | CN | disclosed |
| CN-1185447-A | Propene-1-butene copolymer | SUMITOMO CHEMICAL CO (JP) | 1998-06-24 | — | — | CN | disclosed |
| CN-1151409-A | Olefin polymerizationc atalyst component, olefin polymerizationc atalyst and producing olefin polymer | SUMITOMO CHEMICAL CO (JP) | 1997-06-11 | — | — | CN | disclosed |
| CN-1145370-A | Olefin polymerization catalyst and process for producing polyolefin using the same | SUMITOMO CHEMICAL CO (JP) | 1997-03-19 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12486342-B2 | Cyclopentadienyl/adamantyl phosphinimine zirconium and hafnium complexes | HCFC1, AP1M1, AP3M1 | CA1 431/4885CA2 2984/4885CA4 1885/4885 |
| US-12637524-B2 | Polymerization catalyst having a tetradentate ligand | HAO2, POF1B, DUOX2 | CA1 1542/4885CA2 2537/4885CA4 974/4885 |
| US-20260103484-A1 | TRANSITION METAL COMPOUND, CATALYST COMPOSITION COMPRISING THE SAME, AND METHOD FOR PREPARING OLEFIN POLYMER USING THE SAME | MMP20, CYC1, SOD1 | CA1 141/4885CA2 268/4885CA4 234/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.